Skip to content

Consumer feedback on hair, skin, and nail gummies in healthy adults.

Consumer Feedback on Noochy Hair, Skin, Nail Gummies in Healthy Adult Participants. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/113062
Enrollment
27
Registered
2026-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Noochy Hair Skin Nail Gummies: Manufactured by: SevenQ Nutrition LLP Marketed by : Nuvoly Consumer Products Pvt Ltd Route of Administration: Oral Mode of Usage: Chew gummy thoroughly an

Sponsors

Nuvoly Consumer Products Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Participants of all age groups including paediatric, adult, and geriatric populations. (Age group selection will depend on the test product and its intended use.) 2) Study participants aged between 0 months to 65 years, as specified in the Study Specification Sheet or as per sponsor requirement. 3) Sex: Healthy male and female participants. 4) Females of childbearing potential must have a self-reported negative urine pregnancy test. 5) Participant is in good general health as determined by the Investigator on the basis of medical history. 6) Participants (or parent(s)or legally acceptable representative(s), where applicable) willing to comply with study procedures and provide written informed consent or assent as per regulatory requirements. 7) Participant must be able to understand and provide written Participant s information sheet to participate in the study. 8) Study participants is willing not to use any other marketed product on application site during the study period.

Exclusion criteria

Exclusion criteria: 1) Participant has any known allergy to test product ingredient. 2) Presence of any chronic disease or illness in the past three months or any clinically significant on-going chronic medical illness e.g. Congestive cardiac failure, Hepatitis, Hypotensive episodes, etc. 3) Participation in any similar consumer study within the past 90 days. 4) Currently using any topical medications. 5) Any exceptions to the inclusion or exclusion criteria will be considered on a case-by case basis and will be documented in the case report form.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of test product in terms of improvement in hair, skin, nails by using consumer feedback questionnaire.Timepoint: Baseline, Day 28 and Day 60

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Maheshvari Patel

NovoBliss Research Private Limited

dr.nayan@novobliss.in07948983895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026